GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Interest Expense

Medicure (TSXV:MPH) Interest Expense : C$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medicure's interest expense for the three months ended in Mar. 2024 was C$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medicure's Operating Income for the three months ended in Mar. 2024 was C$ 0.04 Mil. Medicure's Interest Expense for the three months ended in Mar. 2024 was C$ 0.00 Mil. GuruFocus does not calculate Medicure's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medicure Interest Expense Historical Data

The historical data trend for Medicure's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Interest Expense Chart

Medicure Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.05 -0.04 0.02 -0.02

Medicure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.01 - - -

Medicure Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicure  (TSXV:MPH) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medicure's Interest Expense for the three months ended in Mar. 2024 was C$0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was C$0.04 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was C$0.21 Mil.

Medicure's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Medicure's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Medicure Inc has enough cash to cover all of its debt. Its financial situation is stable.

Medicure (TSXV:MPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Interest Expense
Comparable Companies
XCNQ:IMCC TSXV:HASH XCNQ:BAMM TSXV:NDVA XCNQ:XTRX TSX:WLLW TSXV:CANB NEOE:FH TSX:VPH XCNQ:SLNG XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
MCUJF:USA NGQ1:Germany
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Website
https://www.medicure.com
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
Executives
Albert David Friesen Director, Senior Officer

Medicure (TSXV:MPH) Headlines

No Headlines